We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

79 hedge funds and large institutions have $111M invested in BioSpecifics Technologies Corp. in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 24

2% more capital invested

Capital invested by funds: $109M → $111M (+$1.78M)

7% less funds holding

Funds holding: 85 → 79 (-6)

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

Holders
79
Holders Change
-6
Holders Change %
-7.06%
% of All Funds
2.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
33
Reduced
24
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RHJA
Rice Hall James & Associates
California
+$1.53M
2
NC
Northpointe Capital
Michigan
+$1.46M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.34M
4
Allianz Asset Management
Allianz Asset Management
Germany
+$1.23M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$994K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$4.05M
2
TC
TFS Capital
Pennsylvania
-$1.77M
3
Morgan Stanley
Morgan Stanley
New York
-$1.47M
4
DCM
DAFNA Capital Management
California
-$1.29M
5
BIM
Bogle Investment Management
Massachusetts
-$1.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
76
BNP Paribas Financial Markets
France
$3.6K +$3.61K +92 New
Federated Hermes
77
Federated Hermes
Pennsylvania
$1K -$4.27K -109 -94%
Manulife (Manufacturers Life Insurance)
78
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$62 -$549 -14 -0.9%
AC
79
Armistice Capital
New York
– -$4.05M -105,000 Closed
DCM
80
DAFNA Capital Management
California
– -$1.29M -33,466 Closed
BIM
81
Bogle Investment Management
Massachusetts
– -$1.28M -33,180 Closed
DCM
82
Driehaus Capital Management
Illinois
– -$467K -12,100 Closed
PA
83
Perceptive Advisors
New York
– -$234K -6,065 Closed
CCMH
84
Cornerstone Capital Management Holdings
New York
– -$93K -2,400 Closed
BRWA
85
B. Riley Wealth Advisors
Florida
– -$71 -1,827 Closed
Bank of America
86
Bank of America
North Carolina
– -$54K -1,400 Closed
PCM
87
Prelude Capital Management
New York
– -$42K -1,100 Closed
OA
88
OFI Advisors
Pennsylvania
– -$24K -631 Closed
CCS
89
Crosspoint Capital Strategies
California
– -$5K -118 Closed
SEI Investments
90
SEI Investments
Pennsylvania
– -$2K -56 Closed
1 2 3
4

BSTC Hedge Fund Activity: Q1 2015 in Review

79 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2015, worth a combined $111M — up 1.6% from $109M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of BSTC and 6 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 33 added.

The largest buyer was Rice Hall James & Associates, adding an estimated $1.53M. The largest seller was Armistice Capital, exiting entirely with an estimated $4.05M sold.

  • 79 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2015, down from 85 in Q4 2014.
  • Funds reported $111M of BioSpecifics Technologies Corp. stock for Q1 2015, up 1.6% quarter-over-quarter.
  • 6 funds opened new BioSpecifics Technologies Corp. positions in Q1 2015 and 12 closed out, a net change of -6 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q1 2015 was Rice Hall James & Associates, an estimated $1.53M added.
  • The largest BioSpecifics Technologies Corp. seller in Q1 2015 was Armistice Capital, an estimated $4.05M sold.

Based on aggregated 13F filings for Q1 2015.